We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





72nd AACC Annual Scientific Meeting & Clinical Lab Expo Rescheduled to December 13-17, 2020 Due to COVID-19

By LabMedica International staff writers
Posted on 17 Apr 2020
In view of the ongoing spread of COVID-19 across the world and its growing global impact, the American Association for Clinical Chemistry {(AACC) Washington, DC, USA} has decided to reschedule the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo to December in order to ensure a healthy and safe meeting experience for all attendees. More...
The AACC Clinical Lab Expo was originally scheduled to be held July 26-30, 2020 in Chicago, IL, USA.

AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. AACC helps lab professionals adapt to change and provides vital insight and guidance so patients get the care they need. With more than 800 companies exhibiting, the AACC Clinical Lab Expo is the world’s largest exposition for clinical laboratory products and services.

AACC’s leadership has been carefully monitoring the COVID-19 outbreak and consulting members, staff, industry, and other experts. Based on input from all stakeholder groups, and in close collaboration with host city officials, the AACC has announced that it will be able to preserve the complete Annual Scientific Meeting & Clinical Lab Expo experience to which its members, exhibitors, and the entire laboratory medicine community have been looking forward.

The 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will now be held December 13 – 17, 2020 at McCormick Place in Chicago, IL, USA. Rescheduling the event will enable AACC to provide the experience that its attendees and exhibitors expect. The AACC has reaffirmed that the association remains committed to supporting the essential work of laboratory medicine professionals and to holding an event that unites and strengthens the industry in the face of enormous challenges.

Related Links:
American Association for Clinical Chemistry (AACC)


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.